Eckert & Ziegler acquires remaining Shares in EURO-PET Berlin Zyklotron
With the complete takeover of EURO-PET Eckert & Ziegler intends to continue to boost its position on the growing market for radioactive pharmaceutical products. The Holding already has a number of radiopharmaceutical production locations in Germany and markets the approved product Yttriga®, a preliminary stage of many radiotherapy treatments, as well as fluorine-18-based radiodiagnostic compounds for nuclear medical imaging (PET). In addition, Eckert & Ziegler supplies nuclear-imaging facilities around the world with synthesis technology and gallium-68 radionuclide generators.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.